Cargando…
Type 1 Diabetes: A Chronic Anti-Self-Inflammatory Response
Inflammation is typically induced in response to a microbial infection. The release of proinflammatory cytokines enhances the stimulatory capacity of antigen-presenting cells, as well as recruits adaptive and innate immune effectors to the site of infection. Once the microbe is cleared, inflammation...
Autores principales: | Clark, Matthew, Kroger, Charles J., Tisch, Roland M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743904/ https://www.ncbi.nlm.nih.gov/pubmed/29312356 http://dx.doi.org/10.3389/fimmu.2017.01898 |
Ejemplares similares
-
Evolving Antibody Therapies for the Treatment of Type 1 Diabetes
por: Ke, Qi, et al.
Publicado: (2021) -
Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes
por: Kroger, Charles J., et al.
Publicado: (2018) -
The Role of T Cell Receptor Signaling in the Development of Type 1 Diabetes
por: Clark, Matthew, et al.
Publicado: (2021) -
Cumulative Autoimmunity: T Cell Clones Recognizing Several Self-Epitopes Exhibit Enhanced Pathogenicity
por: Liblau, Roland S., et al.
Publicado: (2011) -
The regulation of self-tolerance and the role of inflammasome molecules
por: Ke, Qi, et al.
Publicado: (2023)